FFM
OLMA icon

Fairmount Funds Management’s Olema Pharmaceuticals OLMA Stock Holding History

Fairmount Funds Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,231,566
Closed -$3.4M – 25
2022
Q3 		$3.4M Sell
1,231,566
-1,437,734
-54% -$6.1M 0.6% 25
2022
Q2 		$10.9M Hold
2,669,300
– – 2.49% 17
2022
Q1 		$11.4M Buy
+2,669,300
New +$14.7M 2.69% 16

Other funds holding OLMA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fairmount Funds Management's OLMA Position: Q4 2022 in Review

Fairmount Funds Management sold out of Olema Pharmaceuticals (OLMA) in Q4 2022, closing a stake of 1,231,566 shares — an estimated $3.4M sold.

Fairmount Funds Management first reported a position in OLMA in Q1 2022 and held it in 3 quarters. The position peaked at $11.4M in Q1 2022. 67 funds tracked by Wall St. Rank hold OLMA as of Q4 2022.

  • Fairmount Funds Management reported no remaining Olema Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Fairmount Funds Management sold 1,231,566 Olema Pharmaceuticals shares in Q4 2022, an estimated $3.4M.
  • Fairmount Funds Management first reported a position in Olema Pharmaceuticals in Q1 2022 and held it in 3 quarters.
  • Fairmount Funds Management's Olema Pharmaceuticals position peaked at $11.4M in Q1 2022.
  • 67 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q4 2022.

Based on Fairmount Funds Management's 13F filing for Q4 2022, filed 14 Feb 2023.